Navigation Links
Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
Date:8/30/2010

CINCINNATI, Aug. 31 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today appointed Mark J. Roseman, D.Sc., as the Company's new Senior Vice President and Chief Marketing Officer (CMO), effective immediately. Dr. Roseman brings to Kendle more than 20 years of senior operations leadership and strategic account development experience in the clinical services industry and will have executive-level responsibility for the Company's worldwide sales and strategic partnership development efforts. He will report directly to Chairman and CEO Candace Kendle, PharmD, and will serve on the Company's Executive Committee. Dr. Roseman assumes the Senior Vice President and CMO role from Simon Higginbotham who will transition to an external consulting role providing strategic marketing and business development support services for the Company.

"Mark brings to Kendle a wealth of operational experience and proven sales success in the CRO industry," said Dr. Kendle. "We look forward to his leadership as we drive continued growth in sales and strengthen Kendle's position as a multinational top-tier CRO and strategic partner of choice for our customers."

Dr. Roseman joins Kendle from i3 Research where he was Vice President, Business Operations. His experience includes nearly 13 years with PPD, Inc., where he served most recently as Vice President, Account Management, with responsibility for key customer accounts. Previously, Dr. Roseman was Vice President, Clinical Operations, for PPD responsible for all clinical operations activities in the Wilmington, N.C., and Research Triangle Park offices with oversight of more than 1,100 employees. In this role he provided leadership for the centralized study start-up group as well as the oncology, cardiovascular, anti-viral/anti-infectives, respiratory, ophthalmology, critical care and ge
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
2. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
3. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
4. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
5. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
6. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
7. Kendle Launches New Global Biostatistics Infrastructure
8. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
9. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
10. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
11. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
(Date:1/22/2015)... 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... Omega-3 therapies for cardiovascular disease and overall health is pleased ... in 2014 and its outlook for 2015 from the CEO, ... We would like to take this opportunity to ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... Advocate Christ,Medical Center in Oak Lawn, Ill. has ... area, the only one in the Advocate Health Care ... a glue-like liquid for,the successful treatment of brain aneurysms ... J. Grobelny MD, of,the medical center,s Neurosciences Institute, led ...
... 19 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) ... (NYSE: WYE ), has exercised its option ... to extend the research period for an,additional one-year ... of the,research period extension, Wyeth,s obligations to Trubion ...
Cached Medicine Technology:Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms 2Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 2Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 3
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the American ... effort to further promote visibility and adoption of the top ... AMA journals available via its subscription services, EBSCO will now ... , Long known as both a subscription agency and ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Australian comedian has publicly apologized to sufferers of hepatitis after ... . ,Peter Helliar had cracked a joke ... ,Officials at Hepatitis Australia were annoyed at Helliar's ... the best present for Anderson on her 40th birthday. ...
... fifth-graders prefer larger portions of snacks and fast foods ... according to researchers at Dalhousie University in Canada. ... of portion sizes of french fries, meat, cooked vegetables ... usual portion sizes. , More than 63 ...
... a medical device company founded in 2004 to bring ... surgical markets, announced that vascular surgeons at the ... clinically use their novel high performance vascular sealant, ArterX(TM). ... a 74 year old man suffering from vascular insufficiency ...
... giant pharmaceutical firm is close to developing the world's first ... battle outbreaks, a news report said Friday. ,Clinical ... next year in Thailand, said Jean Stephenne, GlaxoSmithKline Biologicals president. ... the US Army for 10 years, more or less," The ...
... developed a garment with integrated electronic technology that can ... ,When placed on electronic hangers, they enable ... in the wardrobe. So theres no need to worry ... cleaned, according to Professor Bruce Thomas, Director of UniSAs ...
... that HIV/AIDS and kidney transplant patients are at higher ... than the general population. ,The study was ... Andrew Grulich at the University of New South Wales ... ,As part of the study, scientists compared ...
Cached Medicine News:Health News:Tenaxis Medical Inc. Announces First Human Use of Vascular Sealant 2Health News:An Electronic Shirt That Monitors Your Hearts Health 2
Surgical Loupes...
... is the ultimate brain machine. This ... for best image quality and fastest ... a highly compact design. ,These features ... epilepsy, tumor and multiple sclerosis. ,In ...
Signa Profile is built on the Signa foundation to deliver speed & image quality....
... Symphony II Platelet Concentrate System is a ... of Platelet Concentrate (also referred to as ... Poor Plasma (PPP) from a small sample ... the body's natural growth factors, which are ...
Medicine Products: